The Rebirth of Lebrikizumab for Airway Disease.

Pavord ID.

DOI

10.1016/j.jaip.2024.03.020

Type

Journal

J Allergy Clin Immunol Pract

Publication Date

05/2024

Volume

12

Pages

1225 - 1227

Keywords

Humans, Asthma, Antibodies, Monoclonal, Anti-Asthmatic Agents

Permalink Original publication